Skip navigation

Off-Label, Off-Limits?

TREAD CAREFULLY when it comes to off-label discussion: That was the message that came through loud and clear in a 90-minute audioconference called, “Off-Label: Compliance Lessons for Marketing, Sales, and Medical Science Liaisons,” held in early March by HCPro, Marblehead, Mass. As presenter Jane Chin, PhD, said, today's regulatory and legal climate “gives a new meaning to ‘clinical trial.’ Now it's clinical trial by jury.” Chin is president, Medical Science Liaison Institute, and

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.